Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative, Multicenter, Placebo-Controlled, Double-Blind Phase II Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Inhaled Aviptadil in Patients 18 Years and Older With COVID-19 Pulmonary Involvement - HOPE

NCT04844580 is registered in ClinicalTrials.gov with Centurion Pharma as lead sponsor.

NCT NCT04844580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04844580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative, Multicenter, Placebo-Controlled, Double-Blind Phase II Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Inhaled Aviptadil in Patients 18 Years and Older With COVID-19 Pulmonary Involvement - HOPE
Lead sponsor
Centurion Pharma
Phase
Phase 2
Overall status
Completed
Start date
March 10, 2021
Completion date
November 22, 2022
Enrollment
80 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

covid19